Anti-inflammatory effects of orally ingested lactoferrin and glycine in different zymosan-induced inflammation models: Evidence for synergistic activity

International Immunopharmacology

Volumn 7, Issue 13, 2007, Pages 1784-1792

  Hartog, Anita ^a,c   Leenders, Inge ^a   van der Kraan, Peter M ^b   Garssen, Johan ^a,c  

^a NUMICO RESEARCH   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Glycine; Inflammation; Lactoferrin; TNF ; Zymosan

Indexed keywords

GLYCINE; LACTOFERRIN; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL INFILTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; INFLAMMATION; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; SPLEEN CELL; SWELLING;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; GLYCINE; INFLAMMATION; LACTOFERRIN; MALE; MICE; MICE, INBRED BALB C; PROTEOGLYCANS; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 35748947235     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.09.019     Document Type: Article

References (35)

1. Calder P.C., and Fritsche K. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Fatty acids as modulators of the immune response. Am J Clin Nutr 83 6 Suppl (2006) 1505S-1519S
2. Zhong Z., Wheeler M.D., Li X., Froh M., Schemmer P., Yin M., et al. l-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care 6 2 (2003) 229-240
3. Legrand D., Elass E., Carpentier M., and Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 62 22 (2005) 2549-2559
4. Werman R., Davidoff R.A., and Aprison M.H. Inhibition of motoneurones by iontophoresis of glycine. Nature 214 5089 (1967) 681-683
5. Froh M., Thurman R.G., and Wheeler M.D. Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes. Am J Physiol Gastrointest Liver Physiol 283 4 (2002) G856-G863
6. Wheeler M., Stachlewitz R.F., Yamashina S., Ikejima K., Morrow A.L., and Thurman R.G. Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production. FASEB J 14 3 (2000) 476-484
7. Li X., Bradford B.U., Wheeler M.D., Stimpson S.A., Pink H.M., Brodie T.A., et al. Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel. Infect Immun 69 9 (2001) 5883-5891
8. Ikejima K., Iimuro Y., Forman D.T., and Thurman R.G. A diet containing glycine improves survival in endotoxin shock in the rat. Am J Physiol 271 1 Pt 1 (1996) G97-G103
9. Spittler A., Reissner C.M., Oehler R., Gornikiewicz A., Gruenberger T., Manhart N., et al. Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression. FASEB J 13 3 (1999) 563-571
10. Kruzel M.L., Harari Y., Mailman D., Actor J.K., and Zimecki M. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin Exp Immunol 130 1 (2002) 25-31
11. Choe Y.H., and Lee S.W. Effect of lactoferrin on the production of tumor necrosis factor-alpha and nitric oxide. J Cell Biochem 76 1 (1999) 30-36
12. Crouch S.P., Slater K.J., and Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80 1 (1992) 235-240
13. Togawa J., Nagase H., Tanaka K., Inamori M., Nakajima A., Ueno N., et al. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol 17 12 (2002) 1291-1298
14. Zimecki M., Mazurier J., Spik G., and Kapp J.A. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 86 1 (1995) 122-127
15. Zimecki M., Mazurier J., Machnicki M., Wieczorek Z., Montreuil J., and Spik G. Immunostimulatory activity of lactotransferrin and maturation of CD4-CD8-murine thymocytes. Immunol Lett 30 1 (1991) 119-123
16. Hougee S., Hartog A., Sanders A., Graus Y.M., Hoijer M.A., Garssen J., et al. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. Eur J Pharmacol 531 1-3 (2006) 264-269
17. Erdo F., Torok K., Aranyi P., and Szekely J.I. A new assay for antiphlogistic activity: zymosan-induced mouse ear inflammation. Agents Actions 39 3-4 (1993) 137-142
18. Kruijsen M.W., van den Berg W.B., van de Putte L.B., and van den Broek W.J. Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake. Agents Actions 11 6-7 (1981) 640-642
19. Lens J.W., van den Berg W.B., and van de Putte L.B. Quantitation of arthritis by 99mTc-uptake measurements in the mouse knee-joint: correlation with histological joint inflammation scores. Agents Actions 14 5-6 (1984) 723-728
20. van den Berg W.B., Kruijsen M.W., van de Putte L.B., van Beusekom H.J., van der Sluis-van der Pol M., and Zwarts W.A. Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death. Br J Exp Pathol 62 3 (1981) 308-316
21. van de Loo F.A., Joosten L.A., van Lent P.L., Arntz O.J., and van den Berg W.B. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 38 2 (1995) 164-172
22. Nichols J.C., Bronk S.F., Mellgren R.L., and Gores G.J. Inhibition of nonlysosomal calcium-dependent proteolysis by glycine during anoxic injury of rat hepatocytes. Gastroenterology 106 1 (1994) 168-176
23. Morita M., Banno Y., Dohjima T., Nozawa S., Fushimi K., Fan D.G., et al. Mu-calpain is involved in the regulation of TNF-alpha-induced matrix metalloproteinase-3 release in a rheumatoid synovial cell line. Biochem Biophys Res Commun 343 3 (2006) 937-942
24. Yamamoto S., Shimizu K., Suzuki K., Nakagawa Y., and Yamamuro T. Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum 35 11 (1992) 1309-1317
25. Tanida T., Rao F., Hamada T., Ueta E., and Osaki T. Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor. Infect Immun 69 6 (2001) 3883-3890
26. Teraguchi S., Wakabayashi H., Kuwata H., Yamauchi K., and Tamura Y. Protection against infections by oral lactoferrin: evaluation in animal models. BioMetals 17 3 (2004) 231-234
27. Artym J., Zimecki M., and Kruzel M.L. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Immunobiology 207 3 (2003) 197-205
28. Mikhailov V.P., Danilov A.V., and Danilova T.G. Effect of lactoferrin on the development of acute and chronic adjuvant arthritis. Patol Fiziol Eksp Ter 1 (2003) 30-32
29. Hayashida K., Kaneko T., Takeuchi T., Shimizu H., Ando K., and Harada E. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J Vet Med Sci 66 2 (2004) 149-154
30. Guillen C., McInnes I.B., Vaughan D., Speekenbrink A.B., and Brock J.H. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum 43 9 (2000) 2073-2080
31. Wlaszczyk A., Zimecki M., Adamik B., Durek G., and Kubler A. Immunological status of patients subjected to cardiac surgery: effect of lactoferrin on proliferation and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells in vitro. Arch Immunol Ther Exp (Warsz) 45 2-3 (1997) 201-212
32. Sfeir R.M., Dubarry M., Boyaka P.N., Rautureau M., and Tome D. The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice. J Nutr 134 2 (2004) 403-409
33. Chen P.W., Ho S.P., Shyu C.L., and Mao F.C. Effects of bovine lactoferrin hydrolysate on the in vitro antimicrobial susceptibility of Escherichia coli strains isolated from baby pigs. Am J Vet Res 65 2 (2004) 131-137
34. Diarra M.S., Lacasse P., Deschenes E., Grondin G., Paradis-Bleau C., and Petitclerc D. Ultrastructural and cytochemical study of cell wall modification by lactoferrin, lactoferricin and penicillin G against Staphylococcus aureus. J Electron Microsc (Tokyo) 52 2 (2003) 207-215
35. Leon-Sicairos N., Ordaz-Pichardo C., Reyes-Lopez M., and de la Garza M. Microbicidal mechanism of lactoferrin and lactoferricin B and their synergistic effect with metronidazole in Entamoeba histolitica. 7th International Conference on Lactoferrin (2005)